Skip to NavigationSkip to content

News

It was found that 52% of patients receiving the combo therapy survived relapse-free for five years, while only 36% of placebo patients achieved the...
With this latest recommendation, the drug will now also be available for the treatment of advanced squamous or non-squamous NSCLC as a follow-up to...
The illness of one of the participants in the Oxford-AstraZeneca COVID-19 vaccine trial may not have been caused by the treatment itself, according...
The Department of Health and Human Services (HHS) and the Department of Defense (DoD) coordinated with the Centers for Disease Control and Prevention...
Kodak has been cleared of insider trading by an independent review after one of its top executives bought shares before a stock surge following the...
FDA Commissioner Stephen Hahn had opposed the move because of the risks posed by the availability of unverified and potentially inaccurate tests...
Russia attracted criticism when it announced on 11 August that it had approved the world’s first COVID-19 vaccine – based only on data from a Phase 1...
The company has enrolled more than 29,000 people in its 44,000-volunteer trial to test the experimental COVID-19 vaccine it is developing with...
A new study that alleges COVID-19 was created in a Chinese lab was published by two non-profits that are linked to President Trump’s former chief...
The coronavirus news this week focuses on AstraZeneca’s vaccine candidate, as global trials for its much-hyped vaccine were halted after an...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches